1-6 of 6
Natalie Nguyen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract LB505: Design and discovery of MRTX0902, a potent, selective, and orally bioavailable SOS1 inhibitor

Free
John M. Ketcham, David M. Briere, Aaron C. Burns, James G. Christensen, Robin J. Gunn, Jacob Haling, Anthony Ivetac, Shilpi Khare, Jon Kuehler, Svitlana Kulyk, Jade Laguer, John D. Lawson, Krystal Moya, Natalie Nguyen, Peter Olson, Lisa Rahbaek, Christopher R. Smith, Niranjan Sudhakar, Nicole C. Thomas, Darin Vanderpool, Xiaolun Wang, Matthew A. Marx
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): LB505.
https://doi.org/10.1158/1538-7445.AM2022-LB505
Published: 15 June 2022
View articletitled, Abstract LB505: Design and discovery of MRTX0902, a potent, selective, and orally bioavailable SOS1 inhibitor
Journal Articles

Abstract ND02: MRTX0902: A SOS1 inhibitor for therapeutic intervention of KRAS-driven cancers

Free
John M. Ketcham, Shilpi Khare, Niranjan Sudhakar, David M. Briere, Larry Yan, Jade Laguer, Laura Vegar, Darin Vanderpool, Jill Hallin, Lauren Hargis, Vickie Bowcut, David Lawson, Robin J. Gunn, Anthony Ivetac, Nicole C. Thomas, Barbara Saechao, Natalie Nguyen, Jeffrey Clarine, Lisa Rahbaek, Christopher R. Smith, Aaron C. Burns, Matthew A. Marx, James G. Christensen, Peter Olson, Jacob R. Haling
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): ND02.
https://doi.org/10.1158/1538-7445.AM2022-ND02
Published: 15 June 2022
View articletitled, Abstract ND02: MRTX0902: A SOS1 inhibitor for therapeutic intervention of KRAS-driven cancers
Journal Articles

Conditionally replicating oncolytic adenovirus CG5757: Preferential infection in primary human tumor tissues and its potential for systemic application

Free
Yuanhao Li, Trini Arroyo, Steve Thorne, Tony Reid, Natalie Nguyen, Neeraja Idamakanti, Melinda Vanroey, Gail Colbern, De-Chao Yu
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1252.
Published: 01 May 2005
View articletitled, Conditionally replicating oncolytic adenovirus CG5757: Preferential infection in primary human tumor tissues and its potential for systemic application
Journal Articles

Oncolytic adenovirus CG5757 for the treatment of retinoblstoma (Rb) pathway-defective and telomerase-positive cancers.

Free
Yuanhao Li, Orlena Tam, Natalie Nguyen, Melinda Vanroey, Gail Colbern, Trini Arroyo, Derek Ko, De-Chao Yu
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 540.
Published: 01 April 2004
View articletitled, Oncolytic adenovirus CG5757 for the treatment of retinoblstoma (Rb) pathway-defective and telomerase-positive cancers.
Journal Articles

A Hepatocellular Carcinoma-specific Adenovirus Variant, CV890, Eliminates Distant Human Liver Tumors in Combination with Doxorubicin

Free
Yuanhao Li, De-Chao Yu, Yu Chen, Pinky Amin, Hong Zhang, Natalie Nguyen, Daniel R. Henderson
Journal: Cancer Research
Cancer Res (2001) 61 (17): 6428–6436.
Published: 01 September 2001
View articletitled, A Hepatocellular Carcinoma-specific Adenovirus Variant, CV890, Eliminates Distant Human Liver Tumors in Combination with Doxorubicin
Open the PDF for A Hepatocellular Carcinoma-specific Adenovirus Variant, CV890, Eliminates Distant Human Liver Tumors in Combination with Doxorubicin in another window
Journal Articles

Antitumor Synergy of CV787, a Prostate Cancer-specific Adenovirus, and Paclitaxel and Docetaxel

Free
De-Chao Yu, Yu Chen, Jeanette Dilley, Yuanhao Li, Millicent Embry, Hong Zhang, Natalie Nguyen, Pinky Amin, Joe Oh, Daniel R. Henderson
Journal: Cancer Research
Cancer Res (2001) 61 (2): 517–525.
Published: 01 January 2001
View articletitled, Antitumor Synergy of CV787, a Prostate Cancer-specific Adenovirus, and Paclitaxel and Docetaxel
Open the PDF for Antitumor Synergy of CV787, a Prostate Cancer-specific Adenovirus, and Paclitaxel and Docetaxel in another window